Itau Unibanco Holding S.A.’s Editas Medicine EDIT Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2024
Q1
Sell
-2,116
Closed -$21.4K 193
2023
Q4
$21.4K Sell
2,116
-493
-19% -$4.33K ﹤0.01% 277
2023
Q3
$20.4K Buy
2,609
+641
+33% +$5.5K ﹤0.01% 370
2023
Q2
$16.2K Buy
+1,968
New +$17.1K ﹤0.01% 435
2022
Q3
Sell
-35
Closed 574
2022
Q2
$0 Sell
35
-389
-92% -$5.21K ﹤0.01% 522
2022
Q1
$8K Buy
424
+36
+9% +$669 ﹤0.01% 437
2021
Q4
$11K Buy
+388
New +$13.4K ﹤0.01% 394

Other funds holding EDIT

Itau Unibanco Holding S.A.'s EDIT Position: Q1 2024 in Review

Itau Unibanco Holding S.A. sold out of Editas Medicine (EDIT) in Q1 2024, closing a stake of 2,116 shares — an estimated $21.4K sold.

Itau Unibanco Holding S.A. first reported a position in EDIT in Q4 2021 and held it in 6 quarters. The position peaked at $21.4K in Q4 2023. 225 funds tracked by Wall St. Rank hold EDIT as of Q1 2024.

  • Itau Unibanco Holding S.A. reported no remaining Editas Medicine position as of Q1 2024 after selling out during the quarter.
  • Itau Unibanco Holding S.A. sold 2,116 Editas Medicine shares in Q1 2024, an estimated $21.4K.
  • Itau Unibanco Holding S.A. first reported a position in Editas Medicine in Q4 2021 and held it in 6 quarters.
  • Itau Unibanco Holding S.A.'s Editas Medicine position peaked at $21.4K in Q4 2023.
  • 225 funds tracked by Wall St. Rank held Editas Medicine as of Q1 2024.

Based on Itau Unibanco Holding S.A.'s 13F filing for Q1 2024, filed 14 May 2024.